Evidence map›Paper›PMID 40075881›Full record

ArticleDiagnostics (Basel, Switzerland)2025

Comparative Analysis and Validation of the IMPEDED VTE, IMPEDE VTE, and SAVED Risk Models in Predicting Venous Thromboembolism in Multiple Myeloma Patients: A Retrospective Study in Türkiye.

Vildan Gursoy, Mehmet Baysal, Sevil Sadri, Fazil Cagri Hunutlu, Tuba Ersal, Ozgur Omer Gul, Elif Kose, Esra Celik, Serap Baysal, Tuğba Gullu Koca and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Vildan GursoyThe Division of Hematology, The Department of Internal Medicine, The Faculty of Medicine, Uludag University, 16059 Bursa, Türkiye.
Mehmet BaysalThe Department of Hematology, Tekirdag İ. Fehmi Cumalioglu City Hospital, 59030 Tekirdag, Türkiye.ORCID 0000-0001-7681-4623
Sevil SadriThe Division of Hematology, The Department of Internal Medicine, Bursa City Hospital, 16250 Bursa, Türkiye.
Fazil Cagri HunutluThe Division of Hematology, The Department of Internal Medicine, The Faculty of Medicine, Uludag University, 16059 Bursa, Türkiye.ORCID 0000-0002-4991-9830
Tuba ErsalThe Division of Hematology, The Department of Internal Medicine, The Faculty of Medicine, Uludag University, 16059 Bursa, Türkiye.ORCID 0000-0001-5419-3221
Ozgur Omer GulThe Department of Internal Medicine, Bursa City Hospital, 16250 Bursa, Türkiye.
Elif KoseThe Department of Internal Medicine, Bursa City Hospital, 16250 Bursa, Türkiye.
Esra CelikThe Department of Internal Medicine, The Faculty of Medicine, Uludag University, 16059 Bursa, Türkiye.
Serap BaysalThe Department of Public Health, The Faculty of Medicine, Tekirdag Namık Kemal University, 59030 Tekirdag, Türkiye.
Tuğba Gullu KocaThe Division of Hematology, The Department of Internal Medicine, The Faculty of Medicine, Uludag University, 16059 Bursa, Türkiye.
Sinem CubukcuThe Division of Hematology, The Department of Internal Medicine, The Faculty of Medicine, Uludag University, 16059 Bursa, Türkiye.
Ezel ErgunThe Division of Hematology, The Department of Internal Medicine, The Faculty of Medicine, Uludag University, 16059 Bursa, Türkiye.
Seyma YavuzThe Division of Hematology, The Department of Internal Medicine, The Faculty of Medicine, Uludag University, 16059 Bursa, Türkiye.
Vildan OzkocamanThe Division of Hematology, The Department of Internal Medicine, The Faculty of Medicine, Uludag University, 16059 Bursa, Türkiye.
Fahir OzkalemkasThe Division of Hematology, The Department of Internal Medicine, The Faculty of Medicine, Uludag University, 16059 Bursa, Türkiye.ORCID 0000-0001-9710-134X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IMPEDED VTEIMPEDE VTEmultiple myelomathrombotic risk scoresvenous thromboembolism

Identifiers

PMID40075881
PMCPMC11899139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.